Variations in the Hemagglutinin of the 2009 H1N1 Pandemic Virus: Potential for Strains with Altered Virulence Phenotype?


A novel, swine-origin influenza H1N1 virus (H1N1pdm) caused the first pandemic of the 21st century. This pandemic, although efficient in transmission, is mild in virulence. This atypical mild pandemic season has raised concerns regarding the potential of this virus to acquire additional virulence markers either through further adaptation or possibly by immune pressure in the human host. Using the mouse model we generated, within a single round of infection with A/California/04/09/H1N1 (Ca/04), a virus lethal in mice—herein referred to as mouse-adapted Ca/04 (ma-Ca/04). Five amino acid substitutions were found in the genome of ma-Ca/04: 3 in HA (D131E, S186P and A198E), 1 in PA (E298K) and 1 in NP (D101G). Reverse genetics analyses of these mutations indicate that all five mutations from ma-Ca/04 contributed to the lethal phenotype; however, the D131E and S186P mutations—which are also found in the 1918 and seasonal H1N1 viruses—in HA alone were sufficient to confer virulence of Ca/04 in mice. HI assays against H1N1pdm demonstrate that the D131E and S186P mutations caused minor antigenic changes and, likely, affected receptor binding. The rapid selection of ma-Ca/04 in mice suggests that a virus containing this constellation of amino acids might have already been present in Ca/04, likely as minor quasispecies.


Vyšlo v časopise: Variations in the Hemagglutinin of the 2009 H1N1 Pandemic Virus: Potential for Strains with Altered Virulence Phenotype?. PLoS Pathog 6(10): e32767. doi:10.1371/journal.ppat.1001145
Kategorie: Research Article
prolekare.web.journal.doi_sk: 10.1371/journal.ppat.1001145

Souhrn

A novel, swine-origin influenza H1N1 virus (H1N1pdm) caused the first pandemic of the 21st century. This pandemic, although efficient in transmission, is mild in virulence. This atypical mild pandemic season has raised concerns regarding the potential of this virus to acquire additional virulence markers either through further adaptation or possibly by immune pressure in the human host. Using the mouse model we generated, within a single round of infection with A/California/04/09/H1N1 (Ca/04), a virus lethal in mice—herein referred to as mouse-adapted Ca/04 (ma-Ca/04). Five amino acid substitutions were found in the genome of ma-Ca/04: 3 in HA (D131E, S186P and A198E), 1 in PA (E298K) and 1 in NP (D101G). Reverse genetics analyses of these mutations indicate that all five mutations from ma-Ca/04 contributed to the lethal phenotype; however, the D131E and S186P mutations—which are also found in the 1918 and seasonal H1N1 viruses—in HA alone were sufficient to confer virulence of Ca/04 in mice. HI assays against H1N1pdm demonstrate that the D131E and S186P mutations caused minor antigenic changes and, likely, affected receptor binding. The rapid selection of ma-Ca/04 in mice suggests that a virus containing this constellation of amino acids might have already been present in Ca/04, likely as minor quasispecies.


Zdroje

1. LibsterR

BugnaJ

CovielloS

HijanoDR

DunaiewskyM

2010 Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 362 45 55

2. LouieJK

AcostaM

WinterK

JeanC

GavaliS

2009 Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302 1896 1902

3. DonaldsonLJ

RutterPD

EllisBM

GreavesFE

MyttonOT

2009 Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 339 b5213

4. XuR

EkiertDC

KrauseJC

HaiR

CroweJEJr

2010 Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328 357 360

5. HattaM

GaoP

HalfmannP

KawaokaY

2001 Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293 1840 1842

6. ConenelloGM

ZamarinD

PerroneLA

TumpeyT

PaleseP

2007 A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3 1414 1421

7. JacksonD

HossainMJ

HickmanD

PerezDR

LambRA

2008 A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105 4381 4386

8. HaiR

SchmolkeM

VargaZT

ManicassamyB

WangTT

2010 PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol 84 4442 4450

9. HerfstS

ChutinimitkulS

YeJ

de WitE

MunsterVJ

2010 Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol 84 3752 3758

10. TaubenbergerJK

ReidAH

FanningTG

2000 The 1918 influenza virus: A killer comes into view. Virology 274 241 245

11. VincentAL

MaW

LagerKM

JankeBH

RichtJA

2008 Swine influenza viruses a North American perspective. Adv Virus Res 72 127 154

12. MillerRR

MacLeanAR

GunsonRN

CarmanWF

2010 Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10. Euro Surveill 15

13. MakGC

AuKW

TaiLS

ChuangKC

ChengKC

2010 Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 15

14. PotdarVA

ChadhaMS

JadhavSM

MullickJ

CherianSS

2010 Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS ONE 5 e9693

15. KilanderA

RykkvinR

DudmanSG

HungnesO

2010 Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15

16. 2010 Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Wkly Epidemiol Rec 85 21 22

17. BoonAC

deBeauchampJ

HollmannA

LukeJ

KotbM

2009 Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 83 10417 10426

18. SrivastavaB

BlazejewskaP

HessmannM

BruderD

GeffersR

2009 Host genetic background strongly influences the response to influenza a virus infections. PLoS One 4 e4857

19. ItohY

ShinyaK

KisoM

WatanabeT

SakodaY

2009 In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460 1021 1025

20. MunsterVJ

de WitE

van den BrandJM

HerfstS

SchrauwenEJ

2009 Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325 481 483

21. TumpeyTM

BaslerCF

AguilarPV

ZengH

SolorzanoA

2005 Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310 77 80

22. HermannG

TovarCA

BeckFM

AllenC

SheridanJF

1993 Restraint stress differentially affects the pathogenesis of an experimental influenza viral infection in three inbred strains of mice. J Neuroimmunol 47 83 94

23. PerezD

SorrellE

AngelM

YeJ

HickmanD

2009 Fitness of Pandemic H1N1 and Seasonal influenza A viruses during Co-infection: Evidence of competitive advantage of pandemic H1N1 influenza versus seasonal influenza. PLoS Curr Influenza RRN1011

24. GamblinSJ

HaireLF

RussellRJ

StevensDJ

XiaoB

2004 The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303 1838 1842

25. StevensJ

CorperAL

BaslerCF

TaubenbergerJK

PaleseP

2004 Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303 1866 1870

26. SmeenkCA

WrightKE

BurnsBF

ThakerAJ

BrownEG

1996 Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis. Virus Res 44 79 95

27. SmeenkCA

BrownEG

1994 The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J Virol 68 530 534

28. GartenRJ

DavisCT

RussellCA

ShuB

LindstromS

2009 Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325 197 201

29. IgarashiM

ItoK

YoshidaR

TomabechiD

KidaH

2010 Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS ONE 5 e8553

30. SongH

NietoGR

PerezDR

2007 A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol 81 9238 9248

31. MainesTR

JayaramanA

BelserJA

WadfordDA

PappasC

2009 Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325 484 487

32. Al HajjarS

McIntoshK

2010 The first influenza pandemic of the 21st century. Ann Saudi Med 30 1 10

33. GillJR

ShengZM

ElySF

GuineeDG

BeasleyMB

2010 Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 134 235 243

34. LyonJB

RemigioC

MilliganT

DelineC

2010 Acute necrotizing encephalopathy in a child with H1N1 influenza infection. Pediatr Radiol 40 200 205

35. BaltagiSA

ShoykhetM

FelmetK

KochanekPM

BellMJ

2010 Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic. Pediatr Crit Care Med 11 179 184

36. KumarA

ZarychanskiR

PintoR

CookDJ

MarshallJ

2009 Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302 1872 1879

37. HensleySE

DasSR

BaileyAL

SchmidtLM

HickmanHD

2009 Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326 734 736

38. MunsterVJ

de WitE

van den BrandJM

HerfstS

SchrauwenEJ

2009 Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets. Science

39. ReedLJ

MuenchH

1938 A simple method for estimating 50 percent endpoints. Am J Hyg 37 493

40. WanH

SorrellEM

SongH

HossainMJ

Ramirez-NietoG

2008 Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS ONE 3 e2923

41. SorrellEM

WanH

ArayaY

SongH

PerezDR

2009 Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci U S A

42. HoffmannE

StechJ

GuanY

WebsterRG

PerezDR

2001 Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146 2275 2289

43. HoffmannE

KraussS

PerezD

WebbyR

WebsterRG

2002 Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20 3165 3170

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 10
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz

Betablokátory a Ca antagonisté z jiného úhlu
Autori: prof. MUDr. Michal Vrablík, Ph.D., MUDr. Petr Janský

Autori: doc. MUDr. Petr Čáp, Ph.D.

Farmakoterapie akutní a chronické bolesti

Získaná hemofilie - Povědomí o nemoci a její diagnostika

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa